Back to search

National and Kapodistrian University of Athens

Μελέτη του οστικού μεταβολισμού στην κινητοποίηση των αρχέγονων αιμοποιητικών κυττάρων

Abstract

dc:description

Bone as a regulator of human hematopoietic stem cell (HSC) trafficking: Study of biochemical markers of bone remodeling and angiogenic cytokines during HSC mobilization, in patients candicates to autologous hematopoietic stem cell transplantation (AHSCT).Background: The mobilization and collection of peripheral blood stem cells (PBSC) is a standard procedure in the treatment of many hematologic malignancies, both in the autologous and allogeneic stem cell transplantation setting. The proposed mechanisms of HSC mobilization, based on animal models, implicate the G-CSF-mediated proteolytic cleavage of important ligands, such as stromal-derived factor-1 (SDF-1) and the suppression of these ligands on marrow stroma, and especially on osteoblasts (OB). These events abolish the HSC-niche adhesion and lead to HSC mobilization. Today, bone cells are not considered just as a structural, non-functional, supportive tissue for bone marrow, but as HSC-niche regulators. However, there are scarce data regarding the role of bone turnover in HSC mobilization in humans.Aim: To study biochemical markers of bone remodeling and angiogenic cytokines in the process of HSC mobilization of patients with lymphoma and multiple myeloma.Methods: Forty-six patients (18 with Non-Hodgkin lymphoma and 14 with multiple myeloma and Hodgkin lymphoma, respectively) were studied. Serum samples from each patient were collected at two different time points: before the initiation of mobilization (pre-mobilization sample) and on the day of PBSCcollection, which coincided with the highest circulating CD34 counts (collection sample). Moreover, 3 additional serum samples from 19/46 patients were collected, between mobilization and collection. The following molecules were measured by ELISA in patients’ sera: 1) bone resorption markers, carboxyterminal telopeptide of collagen type 1 (CTX), aminoterminal telopeptide of collagen type 1 (NTX) and tartrate resistant acid phosphatase isoform 5b (TRACP-5b), 2) bone formation markers, bone alkaline phosphatase (BALP), osteocalcin (OSC) and osteopontin (OPN), 3) the marker of osteocyte activity dickkopf-1 (DKK-1), an important inhibitor of Wnt-signalling and osteoblastogenesis 4) the osteoclastic regulators receptor activator NF-kB ligand (RANKL) and osteoprotegerin (OPG), 5) angiogenic cytokines angiopoietin-1 (ANGP1), angiopoietin-2 (ANGP2) and angiogenin (ANG), 6) cytokine IL-11, adhesion molecule intercellular adhesion molecule-1 (ICAM-1), chemokine SDF-1 and proteinoglycan Syndecan-1.Values between the two different time points were compared with nonparametric methods. Patients who had either a PBSC (CD34+cells) collection <2.0x106/kg, or a circulating CD34 count peak <20/μL were considered as “poor mobilizers”.Results: The comparison of the molecules under study between the premobilization and collection samples revealed the following: BALP (p=0.000) and OPN (p=0.049) increased significantly between pre-mobilization and collection. OSC, a marker of bone turnover, as well as DKK-1 decreased significantly (p=0.000 and p=0.041, respectively). These findings, all together reveal significant increase of bone formation during HSC mobilization. At the same time, there was a significant increase of RANKL (p=0.000) and OPG (p=0.000) levels, leading to an increase of RANKL/OPG ratio (p=0.000), showing osteoclastogenesis enchacement and osteoclastic activation. This finding was however most prominent in patients with myeloma. Interestingly, there was no evidence of increased osteoclastic activity, as CTX decreased significantly (p=0.026), while both NTX and TRACP-5b did not change. ANGP-1 showed a dramatic reduction (p=0.000), while ANGP-2 increased (p=0.000), resulting in a significant decrease of the ANGP-1/ANGP-2 ratio, a finding indicating significant vessel destabilization during mobilization. The aforementioned results were further supported by the intermediate measurements, which showed a straightforward alteration of bone metabolism early in HSC mobilization. The comparison between good and poor mobilizers revealed that poor mobilizers had significantly higher CTX levels both at pre-mobilization (p=0.004) and collection samples (p=0.001), higher NTX levels at collection (p=0.02), lower ANGP-1 pre-mobilization (p=0.004) and higher OSC at collection (p=0.000) compared to good mobilizers. It seems that CTX, NTX and ANGP-1 premobilization levels may serve as reliable predictors of poor mobilization.Summary/Conclusions: Our study showed for the first time that bone plays adynamic role during human HSC mobilization: Bone formation and vessel destabilization are the two major events and osteoblasts seem to be the major orchestrating cells during this process. Osteoclasts are stimulated, but not fully active. Moreover, several of these markers may identify poor mobilizers.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsirkinidis, Pantelis
  • Τσιρκινίδης, Παντελής

Subjects

dc:subject × 10

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41615

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsirkinidis, Pantelis; Τσιρκινίδης, Παντελής. Μελέτη του οστικού μεταβολισμού στην κινητοποίηση των αρχέγονων αιμοποιητικών κυττάρων. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/41615